Clinical update reveals efsitora alfa improves diabetes management, suggesting a shift in daily medication routines.
Clinical Pharmacology Update| August 18 2025 Breaking the Daily Routine With Insulin Efsitora Alfa, a Once-Weekly Basal Insulin Available to Purchase Emmeline Tran 0000-0003-1062-985X Emmeline Tran Medical University of South Carolina College of Pharmacy, Charleston, SC Corresponding author: Emmeline Tran, [email protected] Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Emmeline Tran, [email protected] Clin Diabetes cd250073 https://doi.org/10.2337/cd25-0073 Views Icon Views Open Menu Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook X LinkedIn Email Cite Icon Cite Get Permissions Citation Emmeline Tran; Breaking the Daily Routine With Insulin Efsitora Alfa, a Once-Weekly Basal Insulin. Clin Diabetes 2025; cd250073. https://doi.org/10.2337/cd25-0073 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search This content is only available via PDF. © 2025 by the American Diabetes Association2025Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. Article PDF first page preview Close Modal You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Emmeline Tran (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: